Tenax Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
783.50
58,320.60
17,126.60
13,280.60
7,727.20
12,862
Total Accounts Receivable
541.50
66.10
76.50
72.60
50.20
-
Inventories
99.20
-
29.50
-
-
-
Other Current Assets
418.10
579.40
278.60
275.00
285.50
458.30
Total Current Assets
1,842.30
58,966.00
17,511.20
13,628.20
8,062.90
13,320.20
Net Property, Plant & Equipment
205.40
124.40
50.30
19.10
9.90
8.50
Total Investments and Advances
-
-
30,975.00
8,586.10
1,809.40
-
Intangible Assets
924.70
34,264.80
33,265.10
-
-
-
Other Assets
208.30
74.20
1,106.80
1,106.80
8.40
8.40
Total Assets
3,180.60
93,429.40
82,936.40
23,340.20
9,890.70
13,337.20
ST Debt & Current Portion LT Debt
57.50
346.90
672.60
-
-
Accounts Payable
977.20
411.10
-
-
-
Other Current Liabilities
874.90
1,813.00
3,844.60
6,199.20
1,008.80
Total Current Liabilities
1,909.60
2,571.00
4,517.20
6,199.20
1,008.80
Long-Term Debt
2,994.40
-
-
-
-
Deferred Taxes
-
7,962.10
7,962.10
-
-
Other Liabilities
54.70
10.90
-
-
-
Total Liabilities
4,958.70
10,544.10
12,507.40
6,199.20
1,008.80
Common Equity (Total)
1,778.00
82,885.40
70,429.00
17,140.90
8,881.90
Total Shareholders' Equity
1,778.00
82,885.40
70,429.00
17,140.90
8,881.90
Total Equity
1,778.00
82,885.40
70,429.00
17,140.90
8,881.90
Liabilities & Shareholders' Equity
3,180.60
93,429.40
82,936.40
23,340.20
9,890.70
Preferred Stock (Carrying Value)
0.00
-
-
-
-
About Tenax Therapeutics
View Profile
